rs199930373
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_014855.3(AP5Z1):āc.1003C>Gā(p.Leu335Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000695 in 1,611,890 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_014855.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AP5Z1 | NM_014855.3 | c.1003C>G | p.Leu335Val | missense_variant | 9/17 | ENST00000649063.2 | NP_055670.1 | |
AP5Z1 | NM_001364858.1 | c.535C>G | p.Leu179Val | missense_variant | 8/16 | NP_001351787.1 | ||
AP5Z1 | XM_047421098.1 | c.667C>G | p.Leu223Val | missense_variant | 7/15 | XP_047277054.1 | ||
AP5Z1 | NR_157345.1 | n.1096C>G | non_coding_transcript_exon_variant | 9/17 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AP5Z1 | ENST00000649063.2 | c.1003C>G | p.Leu335Val | missense_variant | 9/17 | NM_014855.3 | ENSP00000497815 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 152222Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000185 AC: 45AN: 243254Hom.: 1 AF XY: 0.000173 AC XY: 23AN XY: 132654
GnomAD4 exome AF: 0.0000555 AC: 81AN: 1459550Hom.: 2 Cov.: 33 AF XY: 0.0000702 AC XY: 51AN XY: 725980
GnomAD4 genome AF: 0.000203 AC: 31AN: 152340Hom.: 1 Cov.: 33 AF XY: 0.000228 AC XY: 17AN XY: 74490
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 48 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 17, 2023 | This sequence change replaces leucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 335 of the AP5Z1 protein (p.Leu335Val). This variant is present in population databases (rs199930373, gnomAD 0.2%). This variant has not been reported in the literature in individuals affected with AP5Z1-related conditions. ClinVar contains an entry for this variant (Variation ID: 240931). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt AP5Z1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Aug 24, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at